Nishio S - Search Results

1

Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer.

Nishio S, Ushijima K, Yamaguchi T, Sasajima Y, Tsuda H, Kasamatsu T, Kage M, Ono M, Kuwano M, Kamura T. Nishio S, et al. Gynecol Oncol. 2014 Mar;132(3):703-8. doi: 10.1016/j.ygyno.2014.01.045. Epub 2014 Jan 31. Gynecol Oncol. 2014. PMID: 24486603

2

[A case of extraovarian primary peritoneal carcinoma successfully treated with weekly paclitaxel].

Nishio S, Kawata T, Harada C, Kawagoe H, Fujiyoshi K, Ishimatsu J, Tsunawaki A, Sugiyama T, Kamura T. Nishio S, et al. Gan To Kagaku Ryoho. 2002 Feb;29(2):309-12. Gan To Kagaku Ryoho. 2002. PMID: 11865640 Japanese.

3

Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study.

Nishio S, Ota S, Sugiyama T, Matsuo G, Kawagoe H, Kumagai S, Ushijima K, Nishida T, Kamura T. Nishio S, et al. Int J Clin Oncol. 2003 Feb;8(1):45-8. doi: 10.1007/s101470300006. Int J Clin Oncol. 2003. PMID: 12601542

4

Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary.

Nishio S, Ushijima K, Fukui A, Fujiyoshi N, Kawano K, Komai K, Ota S, Fujiyoshi K, Kamura T. Nishio S, et al. J Obstet Gynaecol Res. 2006 Aug;32(4):416-21. doi: 10.1111/j.1447-0756.2006.00417.x. J Obstet Gynaecol Res. 2006. PMID: 16882268

5

Pilot study evaluating the efficacy and toxicity of irinotecan plus oral etoposide for platinum- and taxane-resistant epithelial ovarian cancer.

Nishio S, Sugiyama T, Shouji T, Yoshizaki A, Kitagawa R, Ushijima K, Kamura T. Nishio S, et al. Gynecol Oncol. 2007 Aug;106(2):342-7. doi: 10.1016/j.ygyno.2007.03.036. Epub 2007 May 11. Gynecol Oncol. 2007. PMID: 17499346 Clinical Trial.

6

Polypoid endocervical adenomyoma: a case report with clinicopathologic analyses.

Ota S, Ushijima K, Nishio S, Fujiyoshi N, Takemoto S, Terada A, Kamura T. Ota S, et al. Among authors: nishio s. J Obstet Gynaecol Res. 2007 Jun;33(3):363-7. doi: 10.1111/j.1447-0756.2007.00537.x. J Obstet Gynaecol Res. 2007. PMID: 17578368

7

Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma.

Nishio S, Katsumata N, Matsumoto K, Tanabe H, Yonemori K, Kohno T, Shimizu C, Ando M, Kasamatsu T, Fujiwara Y. Nishio S, et al. Oncol Rep. 2008 Feb;19(2):497-503. Oncol Rep. 2008. PMID: 18202800

8

Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma.

Nishio S, Ushijima K, Tsuda N, Takemoto S, Kawano K, Yamaguchi T, Nishida N, Kakuma T, Tsuda H, Kasamatsu T, Sasajima Y, Kage M, Kuwano M, Kamura T. Nishio S, et al. Cancer Lett. 2008 Jun 8;264(1):36-43. doi: 10.1016/j.canlet.2008.01.020. Epub 2008 Feb 20. Cancer Lett. 2008. PMID: 18281151

9

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.

Nishio S, Katsumata N, Matsumoto K, Tanabe H, Yonemori K, Kouno T, Shimizu C, Ando M, Kamura T, Kasamatsu T, Fujiwara Y. Nishio S, et al. J Cancer Res Clin Oncol. 2009 Apr;135(4):551-7. doi: 10.1007/s00432-008-0488-x. Epub 2008 Oct 1. J Cancer Res Clin Oncol. 2009. PMID: 18830625

10

Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.

Nishio S, Tsuda H, Fujiyoshi N, Ota S, Ushijima K, Sasajima Y, Kasamatsu T, Kamura T, Matsubara O. Nishio S, et al. Pathol Res Pract. 2009;205(5):331-7. doi: 10.1016/j.prp.2008.12.002. Epub 2009 Jan 23. Pathol Res Pract. 2009. PMID: 19167836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,066 results

Search Page

Filters